Supported byClarion Energy
HomeUncategorizedSome medicines scarce...

Some medicines scarce in Serbia

Supported byClarion Owners Engineers
Supported byspot_img
Supported byspot_img

Latest News

Supported byspot_img
Supported bySEE Energy News

Related News

BHP moves to end options on eight Serbian exploration licences

BHP has issued termination notices for its Central Timok and Borsko exploration options in eastern Serbia, returning eight licences to Mundoro Capital when the notices take effect. The miner retains separate Trstenik and South Timok agreements, while Mundoro seeks partners to fund drilling on the returned licences.

Centerra proposes nearly C$4.1 million for 9.9% Mundoro stake

Centerra Gold has agreed to buy 12.374 million newly issued Mundoro Capital shares for approximately C$4.08 million (€2.60 million), in a proposed placement that would give it a 9.9% stake. The funding would support Mundoro’s exploration and working capital as it seeks partners for projects in Serbia, but the deal has not closed.

Northstone secures commitments for about EUR1.45 million Serbia placement

Northstone Resources secured commitments for a share placement worth about EUR1.45 million to fund exploration at its Tlamino gold-silver and Timok East copper-gold projects in Serbia. The financing will support drilling and technical studies, not mine construction.
Supported byVirtu Energy